September 14, 2020 06:51 AM EDTUpdated 10:03 AM
Coronavirus

Covid-19 roundup: Eli Lil­ly de­clares suc­cess on JAK block­er in NIH tri­al; UK gives small biotech a big vac­cine deal

Jason Mast

Editor

The NIH-led study that gave the world the first pos­i­tive, ran­dom­ized remde­sivir re­sult has come back with a sec­ond one, show­ing that, when com­bined with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times